|
|
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
|
5R01CA220551-03
|
$315,193
|
$315,193
|
ZHAO, HAOTIAN
|
NEW YORK INST OF TECHNOLOGY
|
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
$119,807
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
3D Model of Human Ewing Sarcoma
|
3R01CA180279-05S1
|
$221,019
|
$221,019
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies
|
2R44CA203351-03
|
$240,368
|
$120,184
|
MORGAN, LEE
|
DEKK-TEC, INC.
|
|
|
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
|
5R01CA204093-02
|
$392,078
|
$392,078
|
PANDIT-TASKAR, NEETA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
|
5R01CA181231-03
|
$488,144
|
$244,072
|
REITER, JEREMY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-04
|
$311,458
|
$155,729
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
3R01CA174851-05S1
|
$119,204
|
$119,204
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-05
|
$511,226
|
$511,226
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
|
1R01CA227671-01A1
|
$431,631
|
$431,631
|
ZHENG, PAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
7R21CA208618-02
|
$176,380
|
$176,380
|
INTINI, GIUSEPPE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
A novel genetic pathway for survival of B-lymphoblastic leukemia-initiating cells
|
1R21CA209298-01A1
|
$218,588
|
$54,647
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors
|
5K07CA174728-05
|
$164,851
|
$164,851
|
DEVINE, KATIE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma
|
1R43CA221389-01A1
|
$224,919
|
$224,919
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
$77,331
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
$176,605
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
5R00CA175184-04
|
$249,000
|
$249,000
|
IGNATIUS, MYRON
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
Aberrant signaling in acute myeloid leukemia
|
5R01CA204396-03
|
$459,674
|
$114,919
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S1
|
$244,519
|
$2,445
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
$557
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
$652
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
$77,168
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
ABT-199 based therapies to treat neuroblastoma
|
5R01CA215610-02
|
$359,846
|
$359,846
|
FABER, ANTHONY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
|
5R01CA201444-03
|
$367,664
|
$367,664
|
MITTELMAN, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,860,145
|
$55,804
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$546,995
|
$546,995
|
Fry, Terry
|
CCR (NCI)
|
|
|
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu
|
5R03CA212800-02
|
$77,750
|
$77,750
|
HANKINSON, TODD
|
UNIVERSITY OF COLORADO DENVER
|
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$234,427
|
$234,427
|
Fry, Terry
|
CCR (NCI)
|
|
|
Alternate telomere maintenance mechanisms in high-risk neuroblastoma as prognostic indicators and therapeutic targets
|
1R01CA217251-01A1
|
$349,988
|
$349,988
|
REYNOLDS, CHARLES
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
|
AML1-ETO Regulation via the 3UTR in t(8;21) Acute Myeloid Leukemia
|
1F31CA228324-01A1
|
$37,399
|
$9,350
|
JOHNSON, DANIEL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
$3,513,186
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
An integrative approach to identify neuroblastoma immunotherapeutic targets
|
1F31CA225069-01A1
|
$44,524
|
$44,524
|
WEINER, AMBER
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
An mHealth case management system for reducing pediatric cancer treatment abandonment
|
1R21CA217268-01A1
|
$165,868
|
$165,868
|
VASUDEVAN, LAVANYA
|
DUKE UNIVERSITY
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$153,792
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$3,223,418
|
$64,468
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
|
5R01CA211711-02
|
$352,587
|
$352,587
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
|
ARID5B and disparities of childhood leukemia
|
5U01CA176063-05
|
$368,510
|
$368,510
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
|
5F30CA192832-04
|
$41,614
|
$41,614
|
LANG, PATRICK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics
|
1R21CA223503-01A1
|
$207,495
|
$207,495
|
DANDOY, CHRISTOPHER
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
|
5F30CA210334-03
|
$44,724
|
$44,724
|
SCHUELKE, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
$206,625
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$11,888
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$25,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$12,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$320,312
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Best Pharmaceuticals for Children Act (BPCA)
|
NHD12014-001-01164
|
$2,351,618
|
$2,351,618
|
N/A
|
NICHD-NATIONAL INSTITUTE OF CH
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Total relevant funding to Childhood Cancers for this search: $302,325,670
|
